The Acute Lymphoblastic Leukemia (ALL) Therapeutics Market refers to the development and supply of treatment solutions for acute lymphoblastic leukemia, a type of cancer that affects the blood and bone marrow. This aggressive disease is most common in children, but it can affect adults as well. The therapeutics for ALL include chemotherapy, radiation therapy, targeted therapies, immunotherapy, and stem cell transplants, which aim to eliminate cancerous cells and restore normal blood function.